Sonia Moreno–Grau
United States Department of Commerce(US)Galena Biopharma (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Genetic Associations and Epidemiology, Dementia and Cognitive Impairment Research, Bioinformatics and Genomic Networks, Nutrition, Genetics, and Disease
Most-Cited Works
- → Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing(2019)3,123 cited
- → New insights into the genetic etiology of Alzheimer’s disease and related dementias(2022)2,351 cited
- → Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease(2017)1,083 cited
- → Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease(2022)384 cited
- → Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores(2021)325 cited
- → Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project(2019)175 cited
- → Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers(2022)129 cited
- → A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity(2019)129 cited
- → Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment(2016)105 cited
- → The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease(2019)92 cited